Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global interventional cardiology devices market size reached US$ 21.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
Interventional cardiology devices refer to the medical equipment and guiding tools used for performing cardiovascular procedures, such as angioplasty and stenting. Some of the commonly used devices include angioplasty balloons, stents, mitral, pulmonary and tricuspid valves, catheters, plaque modification and hemodynamic flow alteration devices. Along with this, guidewires, vascular closure and hemostasis devices and introducer sheaths are also utilized. These tools and devices are widely used for medical procedures, such as coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), arrhythmia treatment, aneurysm repair, open-heart, off-pump heart and minimally invasive (MI) heart surgeries. They are also used for other procedures, such as atherectomy, embolic protection and percutaneous valve repair.
Interventional Cardiology Devices Market Trends:
The increasing prevalence of diabetes, hypertension and cardiovascular disorders, such as coronary artery disease (CAD, is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Interventional cardiology and embolic protection devices are widely used to capture embolic debris to ensure continuous blood flow and preventing blockages. Additionally, the development of innovative bioabsorbable and drug-eluting stents, pacemakers and drug-coated mesh tubes is acting as another growth-inducing factor. In line with this, the increasing utilization of advanced imaging solutions, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR) and optical coherence tomography (OCT) for early diagnosis and timely treatment of cardiovascular ailments, is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global interventional cardiology devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and end user.
Breakup by Product:
Stents
Drug Eluting Stents
Bare Metal Stents
Bio-Absorbable Stents
Interventional Catheters
IVUS Catheters
Guiding Catheters
Angiography Catheters
PTCA Guidewires
Balloon Inflation Device
PTCA Balloons
Cutting Balloons
Scoring Balloons
Drug Eluting Balloons
Normal Balloons
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.), BIOTRONIK Inc., Boston Scientific Corporation, Cook Group Incorporated, ENDOCOR GmbH, Koninklijke Philips N.V., Medinol Ltd., Medtronic plc and Terumo Corporation.
Key Questions Answered in This Report
1. What was the size of the global interventional cardiology devices market in 2022?
2. What is the expected growth rate of the global interventional cardiology devices market during 2023-2028?
3. What are the key factors driving the global interventional cardiology devices market?
4. What has been the impact of COVID-19 on the global interventional cardiology devices market?
5. What is the breakup of the global interventional cardiology devices market based on the product?
6. What is the breakup of the global interventional cardiology devices market based on the end user?
7. What are the key regions in the global interventional cardiology devices market?
8. Who are the key players/companies in the global interventional cardiology devices market?
Table of Contents
145 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1Objectives of the Study
- 2.2Stakeholders
- 2.3Data Sources
- 2.3.1Primary Sources
- 2.3.2Secondary Sources
- 2.4Market Estimation
- 2.4.1Bottom-Up Approach
- 2.4.2Top-Down Approach
- 2.5Forecasting Methodology
- 3Executive Summary
- 4Introduction
- 4.1Overview
- 4.2Key Industry Trends
- 5Global Interventional Cardiology Devices Market
- 5.1Market Overview
- 5.2Market Performance
- 5.3Impact of COVID-19
- 5.4Market Forecast
- 6Market Breakup by Product
- 6.1Stents
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Drug Eluting Stents
- 6.1.2.2 Bare Metal Stents
- 6.1.2.3 Bio-Absorbable Stents
- 6.1.3 Market Forecast
- 6.2Interventional Catheters
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 IVUS Catheters
- 6.2.2.2 Guiding Catheters
- 6.2.2.3 Angiography Catheters
- 6.2.3 Market Forecast
- 6.3PTCA Guidewires
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4Balloon Inflation Device
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5PTCA Balloons
- 6.5.1 Market Trends
- 6.5.2 Key Segments
- 6.5.2.1 Cutting Balloons
- 6.5.2.2 Scoring Balloons
- 6.5.2.3 Drug Eluting Balloons
- 6.5.2.4 Normal Balloons
- 6.5.3 Market Forecast
- 7Market Breakup by End User
- 7.1Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2Ambulatory Surgical Centers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 8Market Breakup by Region
- 8.1North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.2Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.3Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.5Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
- 9SWOT Analysis
- 9.1Overview
- 9.2Strengths
- 9.3Weaknesses
- 9.4Opportunities
- 9.5Threats
- 10Value Chain Analysis
- 11Porters Five Forces Analysis
- 11.1Overview
- 11.2Bargaining Power of Buyers
- 11.3Bargaining Power of Suppliers
- 11.4Degree of Competition
- 11.5Threat of New Entrants
- 11.6Threat of Substitutes
- 12Price Analysis
- 13Competitive Landscape
- 13.1Market Structure
- 13.2Key Players
- 13.3Profiles of Key Players
- 13.3.1Abbott Laboratories
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2Alvimedica
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3B. Braun Melsungen AG
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 SWOT Analysis
- 13.3.4Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.)
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.5BIOTRONIK Inc.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6Boston Scientific Corporation
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.7Cook Group Incorporated
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.8ENDOCOR GmbH
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9Koninklijke Philips N.V.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10Medinol Ltd.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.11Medtronic plc
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.12Terumo Corporation
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio
- 13.3.12.3 Financials
- 13.3.12.4 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
